Ceftazidime and Glivec drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ceftazidime (ceftazidime) and Glivec (imatinib mesylate). Common drug interactions include septic shock among females and neutropenia among males.

The phase IV clinical study analyzes what interactions people have when they take Ceftazidime and Glivec. It is created by eHealthMe based on reports of 34 people who take the same drugs from the FDA, and is updated regularly.

What is Ceftazidime?

Ceftazidime has active ingredients of ceftazidime. eHealthMe is studying from 10,327 Ceftazidime users. Check the latest studies of Ceftazidime.

What is Glivec?

Glivec has active ingredients of imatinib mesylate. eHealthMe is studying from 17,777 Glivec users. Check the latest studies of Glivec.

On Jul, 13, 2026

34 people who take Ceftazidime and Glivec together, and have interactions are studied.

Ceftazidime and Glivec drug interactions.

What are the common drug interactions of Ceftazidime and Glivec, by gender? *:

female:

Septic shock (shock due to blood infection)

male:

Neutropenia (an abnormally low number of neutrophils)
Pyrexia (fever)
Leukopenia (less number of white blood cells in blood)
Lipase increased
Platelet count decreased
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Herpes virus infection
Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
Sinus tachycardia (a heart rhythm with elevated rate of impulses originating from the sinoatrial node)
Asthenia (weakness)

What are the common drug interactions of Ceftazidime and Glivec, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

Cerebral vasoconstriction (constriction of brain blood vessels)

10-19:

Neutropenia (an abnormally low number of neutrophils)
Pyrexia (fever)
Arthralgia (joint pain)
Catarrh (inflammation of mucous membranes, especially of the nose and throat)
Cough
Pneumonia
Pulmonary mass
Bone marrow failure
Vomiting
Anaemia (lack of blood)

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

Aggression
Psychomotor hyperactivity (feelings of extreme restlessness)
Septic shock (shock due to blood infection)
Thrombocytopenia (decrease of platelets in blood)
Vomiting
Sleep phase rhythm disturbance (heart rate disturbances during sleep)
Abnormal behaviour
Anaemia (lack of blood)
Fungal infection
Leukopenia (less number of white blood cells in blood)

What are the existing conditions these people have? *

Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 33 people, 97.06%
Pneumonia: 4 people, 11.76%
High Blood Pressure: 3 people, 8.82%
Leukopenia (less number of white blood cells in blood): 2 people, 5.88%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 2 people, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Ceftazidime and Glivec?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously